STAAR Surgical Announces Submission of Presbyopia Clinical Trial Data; Proprietary EDOF Collamer® Lens is Designed to Improve Near, Intermediate and Distance Vision

Go back to STAAR Surgical Announces Submission of Presbyopia Clinical Trial Data; Proprietary EDOF Collamer® Lens is Designed to Improve Near, Intermediate and Distance Vision
Staar Surgical Co (NASDAQ: STAA) Delayed: 25.17 --0 (-0%)
Previous Close $25.17    52 Week High $10.95 
Open $25.17    52 Week Low $4.98 
Day High $25.17    P/E N/A 
Day Low $25.17    EPS $-0.01 
Volume 1,178